NCT05005728 · Interventional trial
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Overall registry status Completed
Phase 2
Conditions Metastatic Castration-Resistant Prostate Cancer
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory